VYGR
Voyager Therapeutics, Inc.
-0.01 (-0.33%)3.04USD218K成交股數187M市值–本益比(近四季)5.4股價營收比-39.1%營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 45K |
| 近 180 天 淨額 | −45K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | 04-03 | Sandrock Alfred | President and CEO | S 公開市場賣出(10b5-1) | 11.5K | 3.87 | 45K | 473K | SEC |
| 2026-04-01 | 04-03 | Shiferman Gregory L. | SVP and General Counsel | A 獲配股票 | 50.0K | – | – | 50.0K | SEC |
| 2026-02-24 | 02-26 | Swartz Robin | COO & CBO | S 公開市場賣出(10b5-1) | 6.5K | 3.77 | 24K | 200K | SEC |
| 2026-02-24 | 02-26 | Jorgensen Nathan D. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.7K | 3.77 | 18K | 151K | SEC |
| 2026-02-24 | 02-26 | Sandrock Alfred | President and CEO | S 公開市場賣出(10b5-1) | 14.2K | 3.79 | 54K | 484K | SEC |
| 2026-02-24 | 02-26 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.2K | 3.76 | 16K | 146K | SEC |
| 2026-02-18 | 02-20 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.3K | 3.44 | 11K | 150K | SEC |
| 2026-02-18 | 02-20 | Sandrock Alfred | President and CEO | S 公開市場賣出(10b5-1) | 11.7K | 3.41 | 40K | 498K | SEC |
| 2026-02-18 | 02-20 | Swartz Robin | COO & CBO | S 公開市場賣出(10b5-1) | 3.9K | 3.44 | 13K | 206K | SEC |
| 2026-02-10 | 02-11 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 3.5K | 3.85 | 14K | 153K | SEC |
| 2026-02-10 | 02-11 | Swartz Robin | COO & CBO | S 公開市場賣出 | 4.6K | 3.85 | 18K | 210K | SEC |
| 2026-02-10 | 02-11 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 12.2K | 3.78 | 46K | 510K | SEC |
| 2026-02-06 | 02-10 | Swartz Robin | COO & CBO | A 獲配股票 | 45.0K | – | – | 215K | SEC |
| 2026-02-06 | 02-10 | Sandrock Alfred | President and CEO | A 獲配股票 | 86.3K | – | – | 522K | SEC |
| 2026-02-06 | 02-10 | Carter Todd Alfred | Chief Scientific Officer | A 獲配股票 | 33.0K | – | – | 157K | SEC |
| 2026-02-06 | 02-10 | Ferguson Toby | Chief Medical Officer | A 獲配股票 | 45.0K | – | – | 184K | SEC |
| 2026-02-06 | 02-10 | Jorgensen Nathan D. | Chief Financial Officer | A 獲配股票 | 32.3K | – | – | 156K | SEC |
| 2025-10-03 | 10-07 | Jorgensen Nathan D. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 7.7K | 4.78 | 37K | 124K | SEC |
| 2025-08-18 | 08-20 | Ferguson Toby | Chief Medical Officer | S 公開市場賣出 | 19.0K | 3.73 | 71K | 139K | SEC |
| 2025-04-02 | 04-04 | Ferguson Toby | Chief Medical Officer | S 公開市場賣出 | 10.1K | 3.43 | 35K | 158K | SEC |
| 2025-04-02 | 04-04 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 10.9K | 3.43 | 37K | 431K | SEC |
| 2025-02-21 | 02-24 | Carter Todd Alfred | Chief Scientific Officer | A 獲配股票 | 46.0K | – | – | 124K | SEC |
| 2025-02-21 | 02-24 | Sandrock Alfred | President and CEO | A 獲配股票 | 145K | – | – | 442K | SEC |
| 2025-02-21 | 02-24 | Fahey Sandell Jacquelyn | Chief Legal Officer | A 獲配股票 | 41.5K | – | – | 123K | SEC |
| 2025-02-21 | 02-24 | Swartz Robin | COO & CBO | A 獲配股票 | 71.3K | – | – | 170K | SEC |
| 2025-02-21 | 02-24 | Jorgensen Nathan D. | Chief Financial Officer | A 獲配股票 | 51.5K | – | – | 132K | SEC |
| 2025-02-21 | 02-24 | Ferguson Toby | Chief Medical Officer | A 獲配股票 | 63.0K | – | – | 168K | SEC |
| 2025-02-20 | 02-24 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 3.3K | 4.26 | 14K | 77.7K | SEC |
| 2025-02-20 | 02-24 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 11.7K | 4.24 | 50K | 297K | SEC |
| 2025-02-20 | 02-24 | Swartz Robin | COO & CBO | S 公開市場賣出 | 3.9K | 4.25 | 17K | 98.4K | SEC |
| 2025-02-11 | 02-12 | Fahey Sandell Jacquelyn | Chief Legal Officer | S 公開市場賣出 | 4.4K | 4.45 | 19K | 81.6K | SEC |
| 2025-02-11 | 02-12 | Sandrock Alfred | President & CEO | S 公開市場賣出 | 16.6K | 4.45 | 74K | 309K | SEC |
| 2025-02-11 | 02-12 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 5.4K | 4.45 | 24K | 81.0K | SEC |
| 2025-02-11 | 02-12 | Swartz Robin | COO & CBO | S 公開市場賣出 | 7.0K | 4.45 | 31K | 102K | SEC |
| 2025-01-14 | 01-15 | Swartz Robin | COO & CBO | S 公開市場賣出 | 3.1K | 5.09 | 16K | 109K | SEC |
| 2025-01-14 | 01-15 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 1.2K | 5.13 | 6K | 86.4K | SEC |
| 2024-12-23 | 12-26 | Swartz Robin | COO&CBO | S 公開市場賣出 | 6.5K | 5.65 | 37K | 112K | SEC |
| 2024-10-02 | 10-03 | Fahey Sandell Jacquelyn | Chief Legal Officer | S 公開市場賣出 | 6.0K | 5.82 | 35K | 86.0K | SEC |
| 2024-10-01 | 10-02 | Jorgensen Nathan D. | Chief Financial Officer | A 獲配股票 | 80.0K | – | – | 80.0K | SEC |
| 2024-04-02 | 04-03 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 12.1K | 9.86 | 119K | 323K | SEC |
| 2024-04-02 | 04-03 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 1.4K | 9.88 | 13K | 117K | SEC |
| 2024-04-01 | 04-03 | Ferguson Toby | Chief Medical Officer | A 獲配股票 | 105K | – | – | 105K | SEC |
| 2024-02-21 | 02-22 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 4.0K | 7.45 | 30K | 118K | SEC |
| 2024-02-21 | 02-22 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 13.0K | 7.46 | 97K | 335K | SEC |
| 2024-02-21 | 02-22 | PFREUNDSCHUH PETER P. | Chief Financial Officer | S 公開市場賣出 | 3.8K | 7.46 | 28K | 176K | SEC |
| 2024-02-21 | 02-22 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 3.4K | 7.47 | 25K | 87.6K | SEC |
| 2024-02-20 | 02-22 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 602 | 7.68 | 5K | 91.0K | SEC |
| 2024-02-09 | 02-16 | Swartz Robin | Chief Operating Officer | A 獲配股票 | 50.0K | – | – | 122K | SEC |
| 2024-02-09 | 02-16 | Sandrock Alfred | President and CEO | A 獲配股票 | 130K | – | – | 348K | SEC |
| 2024-02-09 | 02-16 | Fahey Sandell Jacquelyn | Chief Legal Officer | A 獲配股票 | 31.0K | – | – | 92.0K | SEC |
| 2024-02-09 | 02-16 | PFREUNDSCHUH PETER P. | Chief Financial Officer | A 獲配股票 | 30.0K | – | – | 179K | SEC |
| 2024-02-09 | 02-16 | Carter Todd Alfred | Chief Scientific Officer | A 獲配股票 | 38.5K | – | – | 91.6K | SEC |
| 2024-01-17 | 01-19 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 1.3K | 7.18 | 9K | 53.1K | SEC |
| 2024-01-17 | 01-19 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 2.5K | 7.15 | 18K | 72.3K | SEC |
| 2023-10-03 | 10-05 | PFREUNDSCHUH PETER P. | Chief Financial Officer | S 公開市場賣出 | 13.6K | 6.99 | 95K | 149K | SEC |
| 2023-10-01 | 10-02 | Fahey Sandell Jacquelyn | Chief Legal Officer | A 獲配股票 | 61.0K | – | – | 61.0K | SEC |
| 2023-09-15 | 09-18 | Carter Todd Alfred | Chief Scientific Officer | M 選擇權執行 | 5.0K | 2.85 | 14K | 64.9K | SEC |
| 2023-09-15 | 09-18 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 10.5K | 8.16 | 86K | 54.4K | SEC |
| 2023-07-06 | 07-10 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.5K | 10.80 | 59K | 59.9K | SEC |
| 2023-06-30 | 07-05 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.0K | 11.41 | 57K | 65.4K | SEC |
| 2023-06-30 | 07-05 | Carter Todd Alfred | Chief Scientific Officer | M 選擇權執行 | 5.0K | 2.85 | 14K | 70.4K | SEC |
| 2023-04-03 | 04-05 | Sandrock Alfred | President and CEO | S 公開市場賣出 | 7.4K | 7.83 | 58K | 215K | SEC |
| 2023-04-03 | 04-05 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 1.3K | 7.83 | 10K | 71.6K | SEC |
| 2023-03-20 | 03-22 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 3.7K | 7.76 | 28K | 72.9K | SEC |
| 2023-03-20 | 03-22 | Hesslein Robert W. | Senior VP & General Counsel | S 公開市場賣出 | 4.4K | 7.76 | 34K | 102K | SEC |
| 2023-03-20 | 03-22 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 2.2K | 7.76 | 17K | 65.4K | SEC |
| 2023-03-15 | 03-17 | Swartz Robin | Chief Operating Officer | S 公開市場賣出 | 15.4K | 8.20 | 126K | 76.5K | SEC |
| 2023-02-23 | 02-24 | NEUROCRINE BIOSCIENCES INC | TenPercentOwner | P 公開市場買進 | 4.4M | 8.88 | 39.0M | 8.6M | SEC |
| 2023-02-17 | 02-22 | Swartz Robin | Chief Operating Officer | A 獲配股票 | 40.0K | – | – | 91.9K | SEC |
| 2023-02-17 | 02-22 | Sandrock Alfred | President and CEO | A 獲配股票 | 120K | – | – | 222K | SEC |
| 2023-02-17 | 02-22 | PFREUNDSCHUH PETER P. | Chief Financial Officer | A 獲配股票 | 38.0K | – | – | 163K | SEC |
| 2023-02-17 | 02-22 | Hesslein Robert W. | Senior VP & General Counsel | S 公開市場賣出 | 3.3K | 7.45 | 25K | 107K | SEC |
| 2023-02-17 | 02-22 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 738 | 7.45 | 5K | 67.6K | SEC |
| 2023-02-17 | 02-22 | Carter Todd Alfred | Chief Scientific Officer | A 獲配股票 | 34.0K | – | – | 68.3K | SEC |
| 2023-02-13 | 02-15 | Carter Todd Alfred | Chief Scientific Officer | S 公開市場賣出 | 797 | 7.67 | 6K | 34.3K | SEC |
| 2023-02-13 | 02-15 | Hesslein Robert W. | Senior VP & General Counsel | S 公開市場賣出 | 2.9K | 7.67 | 22K | 110K | SEC |
| 2023-02-02 | 02-06 | Third Rock Ventures GP III, L.P. | TenPercentOwner | J 其他 | 1.5M | – | – | 3.2M | SEC |
| 2023-02-02 | 02-06 | TRV GP III, LLC | TenPercentOwner | J 其他 | 1.5M | – | – | 3.2M | SEC |
| 2023-02-02 | 02-06 | Third Rock Ventures III, L.P. | TenPercentOwner | J 其他 | 1.5M | – | – | 3.2M | SEC |
| 2023-02-02 | 02-06 | TEPPER ROBERT I | TenPercentOwner | J 其他 | 1.5M | – | – | 3.2M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 5.2M | 18.1M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 4.4M | 15.6M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 3.4M | 12.0M | 新進 | 新進 |
| Vestal Point Capital, LP | 2.6M | 9.2M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | 8.2M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | 4.7M | 新進 | 新進 |
| Opaleye Management Inc. | 1.2M | 4.1M | 新進 | 新進 |
| STATE STREET CORP | 1.1M | 3.8M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 949K | 3.3M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 838K | 2.9M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 810K | 2.8M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 784K | 2.7M | 新進 | 新進 |
| MORGAN STANLEY | 697K | 2.4M | 新進 | 新進 |
| Erste Asset Management GmbH | 639K | 2.3M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 495K | 1.7M | 新進 | 新進 |
| SPHERA FUNDS MANAGEMENT LTD. | 428K | 1.5M | 新進 | 新進 |
| DIADEMA PARTNERS LP | 414K | 1.4M | 新進 | 新進 |
| NORTHERN TRUST CORP | 412K | 1.4M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 356K | 1.2M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 338K | 1.2M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 337K | 1.2M | 新進 | 新進 |
| Fiduciary Trust Co | 334K | 1.2M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 276K | 989K | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 236K | 826K | 新進 | 新進 |
| PANAGORA ASSET MANAGEMENT INC | 231K | 809K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 136 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 136 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 35.0M · 56.9% |
| 合計季末市值 | 120M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.8M |
|---|---|
| 與上期比 | -4.0% |
| 佔流通股數 | 6.14% |
| 日均成交量 | 427K |
| 回補天數 | 8.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.8M | -4.0% | 6.14% | 427K | 8.9 |
| 2026-08-14 | 3.9M | +8.3% | 6.40% | 448K | 8.8 |
| 2026-07-31 | 3.6M | -5.0% | 5.91% | 623K | 5.9 |
| 2026-07-15 | 3.8M | +7.3% | 6.23% | 839K | 4.6 |
| 2026-06-30 | 3.6M | -2.0% | 5.80% | 698K | 5.1 |
| 2026-06-15 | 3.6M | -2.6% | 5.92% | 503K | 7.3 |
| 2026-05-29 | 3.7M | +7.9% | 6.08% | 615K | 6.1 |
| 2026-05-15 | 3.5M | -5.2% | 5.63% | 541K | 6.4 |
| 2026-04-30 | 3.7M | +2.6% | 5.95% | 424K | 8.6 |
| 2026-04-15 | 3.6M | +8.6% | 5.79% | 635K | 5.6 |
| 2026-03-31 | 3.3M | +3.4% | 5.33% | 662K | 5.0 |
| 2026-03-13 | 3.2M | -0.4% | 5.15% | 1.2M | 2.6 |
| 2026-02-27 | 3.2M | -4.8% | 5.17% | 452K | 7.1 |
| 2026-02-13 | 3.4M | -1.8% | 5.44% | 556K | 6.0 |
| 2026-01-30 | 3.4M | -1.0% | 5.54% | 698K | 4.9 |
| 2026-01-15 | 3.4M | +0.1% | 5.59% | 624K | 5.5 |
| 2025-12-31 | 3.4M | +1.3% | 5.59% | 406K | 8.5 |
| 2025-12-15 | 3.4M | +2.2% | 5.52% | 462K | 7.4 |
| 2025-11-28 | 3.3M | +5.9% | 5.40% | 472K | 7.0 |
| 2025-11-14 | 3.1M | +1.3% | 5.10% | 463K | 6.8 |
| 2025-10-31 | 3.1M | -3.6% | 5.03% | 562K | 5.5 |
| 2025-10-15 | 3.2M | +9.8% | 5.22% | 874K | 3.7 |
| 2025-09-30 | 2.9M | -6.6% | 4.76% | 796K | 3.7 |
| 2025-09-15 | 3.1M | +6.7% | 5.10% | 850K | 3.7 |
| 2025-08-29 | 2.9M | -0.9% | 4.78% | 461K | 6.4 |
| 2025-08-15 | 3.0M | -7.5% | 4.82% | 984K | 3.0 |